189 related articles for article (PubMed ID: 15983026)
41. In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia.
Maisetta G; Mangoni ML; Esin S; Pichierri G; Capria AL; Brancatisano FL; Di Luca M; Barnini S; Barra D; Campa M; Batoni G
Peptides; 2009 Sep; 30(9):1622-6. PubMed ID: 19520127
[TBL] [Abstract][Full Text] [Related]
42. Membrane binding and perturbation studies of the antimicrobial peptides caerin, citropin, and maculatin.
Chia CS; Gong Y; Bowie JH; Zuegg J; Cooper MA
Biopolymers; 2011; 96(2):147-57. PubMed ID: 20564028
[TBL] [Abstract][Full Text] [Related]
43. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Rose WE; Poppens PT
J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
[TBL] [Abstract][Full Text] [Related]
44. Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens.
McNeil MM; Brown JM
Eur J Epidemiol; 1992 May; 8(3):437-43. PubMed ID: 1397208
[TBL] [Abstract][Full Text] [Related]
45. In vitro activities of tachyplesin III against Pseudomonas aeruginosa.
Cirioni O; Giacometti A; Kamysz W; Silvestri C; Riva A; Della Vittoria A; Abbruzzetti A; Lukasiak J; Scalise G
Peptides; 2007 Apr; 28(4):747-51. PubMed ID: 17331619
[TBL] [Abstract][Full Text] [Related]
46. Rhodococcus equi infection in HIV-infected individuals: case reports and review of the literature.
Topino S; Galati V; Grilli E; Petrosillo N
AIDS Patient Care STDS; 2010 Apr; 24(4):211-22. PubMed ID: 20377432
[TBL] [Abstract][Full Text] [Related]
47. Rhodococcus equi pneumonia in a patient with human immunodeficiency virus: case report and review.
Kwa AL; Tam VH; Rybak MJ
Pharmacotherapy; 2001 Aug; 21(8):998-1002. PubMed ID: 11718503
[TBL] [Abstract][Full Text] [Related]
48. Rhodococcus equi infection in a surgical wound.
Paasche SR
Clin Lab Sci; 2009; 22(3):141-5. PubMed ID: 19827407
[TBL] [Abstract][Full Text] [Related]
49. Chemoprophylactic effects of azithromycin against Rhodococcus equi-induced pneumonia among foals at equine breeding farms with endemic infections.
Chaffin MK; Cohen ND; Martens RJ
J Am Vet Med Assoc; 2008 Apr; 232(7):1035-47. PubMed ID: 18380623
[TBL] [Abstract][Full Text] [Related]
50. Pyogenic liver abscess due to Rhodococcus equi in an immunocompetent host.
Napoleão F; Damasco PV; Camello TC; do Vale MD; de Andrade AF; Hirata R; de Mattos-Guaraldi AL
J Clin Microbiol; 2005 Feb; 43(2):1002-4. PubMed ID: 15695730
[TBL] [Abstract][Full Text] [Related]
51. [Long term survival after Rhodococcus equi pneumonia in a patient with human immunodeficiency virus infection in the era of highly active antiretroviral therapy: case report and review].
Vladusić I; Krajinović V; Begovac J
Acta Med Croatica; 2006 Jun; 60(3):259-63. PubMed ID: 16933840
[TBL] [Abstract][Full Text] [Related]
52. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
53. [Soft-tissue abscess caused by Rhodococcus equi in a patient on hemodialysis].
Biechy M; Gálvez E; Salgueró E; Báñez F
Nefrologia; 2001; 21(6):611-2. PubMed ID: 11881436
[No Abstract] [Full Text] [Related]
54. Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections.
Fritsche TR; Rhomberg PR; Sader HS; Jones RN
J Antimicrob Chemother; 2008 May; 61(5):1092-8. PubMed ID: 18310135
[TBL] [Abstract][Full Text] [Related]
55. Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections.
Huang SS; Lee SC; Lee N; See LC; Tsai MH; Shieh WB
J Microbiol Immunol Infect; 2007 Apr; 40(2):134-40. PubMed ID: 17446961
[TBL] [Abstract][Full Text] [Related]
56. Investigation of an apparent outbreak of Rhodococcus equi bacteremia.
Langer AJ; Feja K; Lasker BA; Hinrikson HP; Morey RE; Pellegrini GJ; Smith TL; Robertson C
Diagn Microbiol Infect Dis; 2010 May; 67(1):95-100. PubMed ID: 20385352
[TBL] [Abstract][Full Text] [Related]
57. Rhodococcus equi infection in HIV-positive subjects: a retrospective analysis of 24 cases.
Arlotti M; Zoboli G; Moscatelli GL; Magnani G; Maserati R; Borghi V; Andreoni M; Libanore M; Bonazzi L; Piscina A; Ciammarughi R
Scand J Infect Dis; 1996; 28(5):463-7. PubMed ID: 8953675
[TBL] [Abstract][Full Text] [Related]
58. Susceptibility of Neisseria gonorrhoeae to antimicrobial peptides from amphibian skin, dermaseptin, and derivatives.
Zairi A; Tangy F; Ducos-Galand M; Alonso JM; Hani K
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):319-24. PubMed ID: 17254733
[TBL] [Abstract][Full Text] [Related]
59. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Bhusal Y; Shiohira CM; Yamane N
Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
[TBL] [Abstract][Full Text] [Related]
60. In vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi.
Coleman M; Kuskie K; Liu M; Chaffin K; Libal M; Giguère S; Bernstein L; Cohen N
Vet Microbiol; 2010 Nov; 146(1-2):175-8. PubMed ID: 20554401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
